BR112015022831A2 - Composições farmacêuticas micronizadas - Google Patents
Composições farmacêuticas micronizadasInfo
- Publication number
- BR112015022831A2 BR112015022831A2 BR112015022831A BR112015022831A BR112015022831A2 BR 112015022831 A2 BR112015022831 A2 BR 112015022831A2 BR 112015022831 A BR112015022831 A BR 112015022831A BR 112015022831 A BR112015022831 A BR 112015022831A BR 112015022831 A2 BR112015022831 A2 BR 112015022831A2
- Authority
- BR
- Brazil
- Prior art keywords
- micronized
- powder
- pharmaceutical compositions
- colistimethate sodium
- micrometers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
- B65D75/367—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed and forming several compartments
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
COMPOSIÇÕES FARMACÊUTICAS MICRONIZADAS. São descritas aqui partículas de pó micronizadas do colistimetato sódico, em que pelo menos 50% em volume das partículas micronizadas têm um diâmetro de menos de 7 micrômetros mas não menos de 3 micrômetros e o pó tem um índice de umidade total de 5 a 10% em peso, para o uso no tratamento de uma infecção pulmonar por meio de inalação de pó, em que o colistimetato sódico não é separado na forma de componente. As partículas de pó micronizadas do colistimetato sódico são úteis no tratamento das infecções causadas pelas bactérias de gram-negativas, particularmente nos pacientes que sofrem de fibrose cística.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779057P | 2013-03-13 | 2013-03-13 | |
PCT/US2014/021698 WO2014164280A1 (en) | 2013-03-13 | 2014-03-07 | Micronized pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015022831A2 true BR112015022831A2 (pt) | 2017-08-22 |
Family
ID=51658844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015022831A BR112015022831A2 (pt) | 2013-03-13 | 2014-03-07 | Composições farmacêuticas micronizadas |
Country Status (15)
Country | Link |
---|---|
US (1) | US10441536B2 (pt) |
EP (1) | EP2968161A4 (pt) |
JP (1) | JP6461902B2 (pt) |
KR (1) | KR20180092324A (pt) |
CN (1) | CN105555257A (pt) |
AU (1) | AU2014249529B2 (pt) |
BR (1) | BR112015022831A2 (pt) |
CA (1) | CA2912485A1 (pt) |
CL (1) | CL2015002702A1 (pt) |
IL (1) | IL241283A0 (pt) |
MX (1) | MX2015012931A (pt) |
RU (1) | RU2659385C2 (pt) |
SG (1) | SG11201507466XA (pt) |
WO (1) | WO2014164280A1 (pt) |
ZA (1) | ZA201506637B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2970383T3 (da) | 2013-03-15 | 2021-07-05 | Univ Texas | Fremgangsmåde til behandling af fibrose |
US10617703B2 (en) * | 2014-12-10 | 2020-04-14 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
CA3111563A1 (en) | 2018-09-10 | 2020-03-19 | Lung Therapeutics, Inc. | Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis |
US20210260150A1 (en) * | 2018-09-10 | 2021-08-26 | Board Of Regents, The University Of Texas System | Dry powder formulation of caveolin-1 peptides and methods of use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US16745A (en) * | 1857-03-03 | Improvement in sewing-machines | ||
GB9820746D0 (en) * | 1998-09-23 | 1998-11-18 | Pharmax Limited | Micronised pharmaceutical compositions |
US20040060265A1 (en) * | 2002-06-27 | 2004-04-01 | Nektar Therapeutics | Controlling the flow of a powder |
JO3102B1 (ar) | 2004-03-17 | 2017-09-20 | Chiesi Framaceutici S P A | صيغ صيدلانية لوسائل استنشاق بها مسحوق جاف تشتمل على مكون فعال بقوة منخفضة الجرعة |
ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
PT105065B (pt) * | 2010-04-26 | 2012-07-31 | Hovione Farmaciencia S A | Um inalador simples de cápsulas |
WO2012061902A1 (en) * | 2010-11-12 | 2012-05-18 | Monash University | Micronised spray-dried particles comprising polymyxin |
-
2014
- 2014-03-07 RU RU2015143135A patent/RU2659385C2/ru not_active IP Right Cessation
- 2014-03-07 CA CA2912485A patent/CA2912485A1/en not_active Abandoned
- 2014-03-07 CN CN201480025155.9A patent/CN105555257A/zh active Pending
- 2014-03-07 JP JP2016500810A patent/JP6461902B2/ja not_active Expired - Fee Related
- 2014-03-07 US US14/772,748 patent/US10441536B2/en not_active Expired - Fee Related
- 2014-03-07 MX MX2015012931A patent/MX2015012931A/es unknown
- 2014-03-07 KR KR1020157028634A patent/KR20180092324A/ko not_active Application Discontinuation
- 2014-03-07 AU AU2014249529A patent/AU2014249529B2/en not_active Ceased
- 2014-03-07 EP EP14778370.8A patent/EP2968161A4/en not_active Ceased
- 2014-03-07 BR BR112015022831A patent/BR112015022831A2/pt not_active Application Discontinuation
- 2014-03-07 WO PCT/US2014/021698 patent/WO2014164280A1/en active Application Filing
- 2014-03-07 SG SG11201507466XA patent/SG11201507466XA/en unknown
-
2015
- 2015-09-07 IL IL241283A patent/IL241283A0/en unknown
- 2015-09-08 ZA ZA2015/06637A patent/ZA201506637B/en unknown
- 2015-09-14 CL CL2015002702A patent/CL2015002702A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US10441536B2 (en) | 2019-10-15 |
JP2016512260A (ja) | 2016-04-25 |
SG11201507466XA (en) | 2015-10-29 |
KR20180092324A (ko) | 2018-08-20 |
JP6461902B2 (ja) | 2019-01-30 |
MX2015012931A (es) | 2016-07-20 |
IL241283A0 (en) | 2015-11-30 |
RU2659385C2 (ru) | 2018-06-29 |
US20160022577A1 (en) | 2016-01-28 |
EP2968161A4 (en) | 2016-10-26 |
CL2015002702A1 (es) | 2016-08-12 |
AU2014249529A1 (en) | 2015-10-01 |
RU2015143135A (ru) | 2017-04-28 |
AU2014249529B2 (en) | 2018-08-09 |
ZA201506637B (en) | 2016-11-30 |
CN105555257A (zh) | 2016-05-04 |
EP2968161A1 (en) | 2016-01-20 |
CA2912485A1 (en) | 2014-10-09 |
WO2014164280A8 (en) | 2015-04-09 |
WO2014164280A1 (en) | 2014-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016022598A8 (pt) | composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso | |
BR112018004532A2 (pt) | uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos | |
BR112016003229A8 (pt) | composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica | |
JP2014507482A5 (pt) | ||
BR112015021352A2 (pt) | composições antimicrobianas | |
BR112015023412A8 (pt) | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante, sua composição farmacêutica e seu uso. | |
PE20190406A1 (es) | Composiciones farmaceuticas que comprenden bromuro de aclidinio | |
BR112012023660B8 (pt) | usos de uma quantidade terapeuticamente eficaz de um composto, ou de um sal, solvato, hidrato ou pró-fármaco farmaceuticamente aceitável do mesmo para o tratamento de câncer | |
BR112015022831A2 (pt) | Composições farmacêuticas micronizadas | |
BR112018006368A2 (pt) | composição para desempenho melhorado | |
PE20141048A1 (es) | Combinacion que comprende umeclidinio y un corticosteroide | |
BR112015027017A2 (pt) | composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas | |
BR112014003640A8 (pt) | métodos para perda de peso e composições cetogênicas | |
BR112014013923A8 (pt) | método para produção de mulita percolada num corpo de material, mulita percolada, uso da mulita percolada e corpo de material | |
BR112016003584A8 (pt) | composições farmaceuticas e uso das mesmas para regressão de placa acelerada | |
BR112014018767A8 (pt) | Compostos de pirroldicarboxamidas fundidas e composição farmacêutica que os compreende | |
CL2016001094A1 (es) | Silicato de zirconio microporoso para el tratamiento de hipercalemia. | |
BR112014005538A2 (pt) | composições aquosas compreendendo arbecacina | |
UA118192C2 (uk) | Противірусна фармацевтична композиція | |
BR112015027247A2 (pt) | composições farmacêuticas inaláveis e dispositivos inaladores contendo as mesmas | |
BR112015010651A2 (pt) | composição antiparasitária de amplo espectro de nitazoxanida, probióticos e prebióticos | |
BR112015030072A2 (pt) | uma composiçaõ farmacêutica para a profilaxia e o tratamento de doenças de etiologia infecciosa | |
EA201500446A1 (ru) | Фармацевтическая композиция для снижения уровня n-оксида триметиламина | |
BR112015031122A2 (pt) | composição bucal indicativa de limpeza de dentes adequada | |
TR200907913A2 (tr) | İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: FOREST LABORATORIES HOLDINGS LIMITED (BM) |
|
B25A | Requested transfer of rights approved |
Owner name: ACTAVIS GROUP PTC EHF (IS) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |